Reflecting on ConPharm 2022
June 23, 2022
PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and Qld Local Advisory Committee Chair) were pleased to attend ConPharm 2022 at Sea
PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and Qld Local Advisory Committee Chair) were pleased to attend ConPharm 2022 at Sea
The recent surge in demand for influenza vaccines has also seen a rise in the number of vaccine-related calls and incident reports to PDL. This
As winter approaches, pharmacies will be very busy providing vaccinations against influenza (flu) as well as administering COVID-19 fourth doses (winter doses) or boosters. As
All students and interns are registered with AHPRA, and therefore have the responsibility to comply with the guidelines and protocols associated with registration. As pharmacists
PDL is aware of multiple instances where a pharmacist has not realised a prescription needs to be compounded. This may be due to misinterpretation of
Professional Indemnity insurance (PI insurance or PII) may seem like an uninteresting topic, however, the relevance becomes very clear if there is action taken against
The ATAGI approval of Moderna Spikevax for the primary vaccination of children 6-11 years provides more options for families and pharmacists. Read the ATAGI statement.
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 30,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,
PDL would like to remind pharmacists that ALL private prescriptions presented for potent opioids should be treated with high suspicion. Prescriptions for high-dose fentanyl patches and oxycodone tablets make up more
The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from 10 January 2022 offers opportunities and challenges for pharmacists. PDL encourages pharmacists to prepare for this